Sygnature Discovery Appoints Dr Charles Woler As ChairmanGemma Cann2024-11-28T15:17:03+00:00January 14th, 2022|BioCity Nottingham, News|
NuVision Biotherapies Announces The Appointment Of New CEO And COOGemma Cann2024-11-28T15:30:12+00:00January 14th, 2022|MediCity Nottingham, News|
Gateley Acquires IP Specialists Adamson JonesGemma Cann2022-06-30T11:45:01+01:00January 13th, 2022|BioCity Nottingham, News|
Oxomics’ New Blood-Based Test The First To Identify If A Patient Has Cancer And If It Has SpreadGemma Cann2024-11-28T16:54:08+00:00January 11th, 2022|News|
Novosound Enters Global Digital Health MarketGemma Cann2022-06-30T11:46:29+01:00January 5th, 2022|BioCity Glasgow, News|
Pioneer Group Accelerator Winner Announced: Pioneering Start-up Oxomics Receives £50KGemma Cann2023-09-04T12:48:30+01:00December 17th, 2021|Accelerator, News|
Finalists Announced For The Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:30:27+00:00December 15th, 2021|BioCity Nottingham, MediCity Nottingham, News|
Symrise Opens Innovation Lab Located At Colworth Science ParkGemma Cann2024-11-28T15:21:14+00:00December 15th, 2021|Colworth Park, News|
New CFO Jordison Steps Up At Sygnature DiscoveryGemma Cann2024-11-28T15:19:23+00:00December 8th, 2021|BioCity Nottingham, News|
Award Winning Business Helping to Combat Deadliest DiseasesGemma Cann2023-09-04T12:54:30+01:00November 29th, 2021|News, Wilton Centre|
